Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Lilia-Celine Lozada is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/27/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/27/2025 | ATRC | Buy Now | AtriCure | $34.37 | 33.84% | Lilia-Celine Lozada43% | $51 → $46 | Maintains | Overweight | Get Alert |
| 02/11/2025 | ATRC | Buy Now | AtriCure | $34.37 | 48.39% | Lilia-Celine Lozada43% | $40 → $51 | Maintains | Overweight | Get Alert |
| 12/17/2024 | TMCI | Buy Now | Treace Medical Concepts | $8.37 | -4.42% | Lilia-Celine Lozada43% | → $8 | Assumes | → Neutral | Get Alert |
| 12/17/2024 | ATRC | Buy Now | AtriCure | $34.37 | 16.38% | Lilia-Celine Lozada43% | → $40 | Assumes | → Overweight | Get Alert |
